CRs before a company changing event is not unheard of, especially if the company needs cash to properly captilise on the momentum ahead of, or after, said event. My understanding is the FDA approval has already been delayed once. It may have been intended to be after, if at all previously required but who knows.
CRs before a company changing event is not unheard of,...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $123.5M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.0¢ | 21.0¢ | $118.1K | 558.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 167903 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 58374 | 3 |
View Market Depth
| Last trade - 11.45am 27/09/2024 (20 minute delay) ? |
| EIQ (ASX) Chart |